药剂师处方权：来自爱达荷州的经验教训。
Pharmacist Prescriptive Authority: Lessons from Idaho.
作者信息
Adams Alex J
机构信息
Idaho State Board of Pharmacy, Boise, ID 83702, USA.
出版信息
Pharmacy (Basel). 2020 Jul 8;8(3):112. doi: 10.3390/pharmacy8030112.
Abstract
Pharmacist prescriptive authority continues to increase at the state level in the United States. Recently, the Idaho Board of Pharmacy (BOP) finalized regulations that expanded autonomous prescriptive authority in its state to a range of preventative care as well as acute and chronic conditions. This manuscript reviews the key decision points made by the BOP regarding drug categories included, education requirements, protocols, access to data, and use of standards of care. Overall, Idaho's approach closely reflects the medical model of regulation and may prove useful to other states and jurisdictions as they consider similar issues.
摘要
在美国，药剂师的处方权在州一级持续增加。最近，爱达荷州药剂师委员会（BOP）最终确定了相关法规，将该州的自主处方权扩大到一系列预防保健以及急性和慢性疾病领域。本文回顾了药剂师委员会在药物类别、教育要求、方案、数据获取和护理标准使用等方面做出的关键决策点。总体而言，爱达荷州的做法紧密反映了监管的医学模式，并可能对其他州和司法管辖区在考虑类似问题时有所帮助。
相似文献
1
Pharmacist Prescriptive Authority: Lessons from Idaho.药剂师处方权：来自爱达荷州的经验教训。
Pharmacy (Basel). 2020 Jul 8;8(3):112. doi: 10.3390/pharmacy8030112.
2
Rethinking pharmacy regulation: Core elements of Idaho's transition to a "Standard of Care" approach.重新思考药房监管：爱达荷州向“护理标准”方法过渡的核心要素。
J Am Pharm Assoc (2003). 2020 Nov-Dec;60(6):e109-e112. doi: 10.1016/j.japh.2020.07.013. Epub 2020 Aug 8.
3
The Continuum of Pharmacist Prescriptive Authority.药剂师处方权的连续性
Ann Pharmacother. 2016 Sep;50(9):778-84. doi: 10.1177/1060028016653608. Epub 2016 Jun 15.
4
Pathways to pharmacist prescriptive authority: Do decentralized models for expanded prescribing work?药剂师处方权限的途径：扩大处方的分散模式是否有效？
Res Social Adm Pharm. 2022 Apr;18(4):2695-2699. doi: 10.1016/j.sapharm.2021.07.016. Epub 2021 Jul 17.
5
Use of research evidence varied in efforts to expand specific pharmacist autonomous prescriptive authority: an evaluation and recommendations to increase research utilization.在努力扩大特定药师自主处方权限的过程中，研究证据的使用存在差异：评估和建议以增加研究的利用。
Health Res Policy Syst. 2022 Jan 3;20(1):1. doi: 10.1186/s12961-021-00789-9.
6
Federal pharmacist Paxlovid prescribing authority: A model policy or impediment to optimal care?联邦药剂师开具帕罗韦德（Paxlovid）的处方权：一项模范政策还是优化治疗的障碍？
Explor Res Clin Soc Pharm. 2023 Mar;9:100244. doi: 10.1016/j.rcsop.2023.100244. Epub 2023 Mar 14.
7
Initial perceptions of key stakeholders in Ontario regarding independent prescriptive authority for pharmacists.安大略省主要利益相关者对药剂师独立处方权的初步看法。
Res Social Adm Pharm. 2014 Mar-Apr;10(2):341-54. doi: 10.1016/j.sapharm.2013.05.008. Epub 2013 Jun 28.
8
Pharmacist-led Smoking-Cessation Services in the United States - A Multijurisdictional Legal Analysis.美国药剂师主导的戒烟服务——多辖区法律分析
Innov Pharm. 2022 Apr 2;13(1). doi: 10.24926/iip.v13i1.4643. eCollection 2022.
9
Extending COVID-19 Pharmacy Technician Duties: Impact on Safety and Pharmacist Jobs.扩大新冠病毒肺炎药剂师技术员职责：对安全性和药剂师工作的影响
J Pharm Technol. 2023 Jun;39(3):134-138. doi: 10.1177/87551225231172343. Epub 2023 May 24.
10
Update and recommendations: Pharmacists' prescriptive authority for tobacco cessation medications in the United States.最新情况与建议：美国药剂师对戒烟药物的处方权
J Am Pharm Assoc (2003). 2022 Sep-Oct;62(5):1531-1537. doi: 10.1016/j.japh.2022.06.005. Epub 2022 Jun 18.
引用本文的文献
1
Regulating pharmacist services: Achieving a full scope of practice.规范药剂师服务：实现全面执业范围。
Can Pharm J (Ott). 2023 Jul 25;156(5):231-234. doi: 10.1177/17151635231188330. eCollection 2023 Sep-Oct.
2
Implementation of the California advanced practice pharmacist and the continued disappointment of tiered licensure.加利福尼亚高级执业药师的实施以及分级许可制持续令人失望的情况。
Explor Res Clin Soc Pharm. 2023 Oct 20;12:100353. doi: 10.1016/j.rcsop.2023.100353. eCollection 2023 Dec.
3
Federal pharmacist Paxlovid prescribing authority: A model policy or impediment to optimal care?联邦药剂师开具帕罗韦德（Paxlovid）的处方权：一项模范政策还是优化治疗的障碍？
Explor Res Clin Soc Pharm. 2023 Mar;9:100244. doi: 10.1016/j.rcsop.2023.100244. Epub 2023 Mar 14.
4
Evaluation of Point-of-Care Testing in Pharmacy to Inform Policy Writing by the New Brunswick College of Pharmacists.新不伦瑞克药剂师学院对药房即时检验进行评估以指导政策制定。
Pharmacy (Basel). 2022 Nov 26;10(6):159. doi: 10.3390/pharmacy10060159.
5
Pharmacy-Based Point-of-Care Testing: How a "Standard of Care" Approach Can Facilitate Sustainability.基于药房的即时检验：“医疗护理标准”方法如何促进可持续性。
Innov Pharm. 2021 Sep 22;12(4). doi: 10.24926/iip.v12i4.4290. eCollection 2021.
6
Minnesota Policy on Pharmacist-Prescribed Contraceptives: Benefits, Limitations, and Opportunities for Improvement.明尼苏达州药剂师开处方的避孕药政策：益处、局限性及改进机会
Innov Pharm. 2021 Jun 10;12(3). doi: 10.24926/iip.v12i3.3923. eCollection 2021.
7
Pharmacist Prescriptive Authority for Acne: An Evidence-Based Approach to Policy.药剂师对痤疮的处方权：基于证据的政策制定方法。
Innov Pharm. 2021 Apr 27;12(2). doi: 10.24926/iip.v12i2.3897. eCollection 2021.
8
Does Increased State Pharmacy Regulatory Burden Lead to Better Public Safety Outcomes?州药房监管负担的增加会带来更好的公共安全结果吗？
Innov Pharm. 2021 Mar 2;12(1). doi: 10.24926/iip.v12i1.3598. eCollection 2021.
9
Eliminating the Board of Pharmacy's Role in Designating a Pharmacist-in-Charge.取消药房委员会在指定药剂负责人方面的职责。
Innov Pharm. 2020 Jul 31;11(3). doi: 10.24926/iip.v11i3.3371. eCollection 2020.
10
Pharmacy-Based Assessment and Management of Herpes Labialis (Cold Sores) with Antiviral Therapy.基于药房的唇疱疹（唇疮疹）抗病毒治疗评估与管理
Innov Pharm. 2020 Jul 31;11(3). doi: 10.24926/iip.v11i3.1532. eCollection 2020.
本文引用的文献
1
Rethinking pharmacy regulation: Core elements of Idaho's transition to a "Standard of Care" approach.重新思考药房监管：爱达荷州向“护理标准”方法过渡的核心要素。
J Am Pharm Assoc (2003). 2020 Nov-Dec;60(6):e109-e112. doi: 10.1016/j.japh.2020.07.013. Epub 2020 Aug 8.
2
Outcomes of Urinary Tract Infection Management by Pharmacists (ROUTMAP): A study of pharmacist prescribing and care in patients with uncomplicated urinary tract infections in the community.药剂师管理尿路感染的结果（ROUTMAP）：一项关于社区非复杂性尿路感染患者药剂师开处方及护理的研究。
Can Pharm J (Ott). 2018 Jun 3;151(5):305-314. doi: 10.1177/1715163518781175. eCollection 2018 Sep-Oct.
3
Transitioning pharmacy to "standard of care" regulation: Analyzing how pharmacy regulates relative to medicine and nursing.将药学过渡到“标准护理”监管：分析药学相对于医学和护理的监管方式。
Res Social Adm Pharm. 2019 Oct;15(10):1230-1235. doi: 10.1016/j.sapharm.2018.10.008. Epub 2018 Oct 16.
4
An Innovative Approach to Improving the Proposed CMS Star Rating "Statin Use in Persons with Diabetes".一种改进 CMS 星评分“糖尿病患者使用他汀类药物”的创新方法。
J Manag Care Spec Pharm. 2018 Nov;24(11):1126-1129. doi: 10.18553/jmcp.2018.24.11.1126.
5
Pharmacy-based management of influenza: lessons learned from research.基于药房的流感管理：研究经验教训
Int J Pharm Pract. 2018 Dec;26(6):573-578. doi: 10.1111/ijpp.12488. Epub 2018 Sep 28.
6
FAQs (frequent asinine questions) on pharmacists' scope of practice.关于药剂师执业范围的常见愚蠢问题（FAQs）
Can Pharm J (Ott). 2018 Jun 4;151(4):212-213. doi: 10.1177/1715163518779790. eCollection 2018 Jul-Aug.
7
Do naloxone access laws increase outpatient naloxone prescriptions? Evidence from Medicaid.纳洛酮获取法是否会增加门诊纳洛酮处方？来自医疗补助计划的证据。
Drug Alcohol Depend. 2018 Sep 1;190:37-41. doi: 10.1016/j.drugalcdep.2018.05.014. Epub 2018 Jun 22.
8
The Roles of Pharmacy Schools in Bridging the Gap Between Law and Practice.药学专业在弥合法学与实践之间差距中的作用。
Am J Pharm Educ. 2018 May;82(4):6577. doi: 10.5688/ajpe6577.
9
Pharmacist prescriptive authority for smoking cessation medications in the United States.美国药剂师对戒烟药物的处方权。
J Am Pharm Assoc (2003). 2018 May-Jun;58(3):253-257. doi: 10.1016/j.japh.2017.12.015. Epub 2018 Feb 14.
10
Are advanced practice pharmacist designations really advanced?高级实践药剂师的称号真的高级吗？
Res Social Adm Pharm. 2018 May;14(5):501-504. doi: 10.1016/j.sapharm.2017.10.002. Epub 2017 Oct 7.
Zotero 插件